SEC Filing Summary: Aimei Health Technology Co., Ltd. (AFJK)
Business Context and Reporting Period
This Form 8-K was filed on August 21, 2026, by Aimei Health Technology Co., Ltd., a Cayman Islands corporation. The report addresses a critical regulatory event concerning the company's continued listing status on The Nasdaq Global Market.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The only quantitative financial data disclosed relates to market capitalization thresholds:
- Market Value of Listed Securities (MVLS): Below $50,000,000 for the last 30 consecutive business days.
- Market Value of Publicly Held Shares (MVPHS): Below $15,000,000 for the last 30 consecutive business days.
Material Changes and Events
The company received two notices from Nasdaq on August 21, 2026, citing non-compliance with listing rules:
- MVLS Notice: Failure to meet the $50 million minimum MVLS requirement under Nasdaq Listing Rule 5450(b)(2)(A).
- MVPHS Notice: Failure to meet the $15 million minimum MVPHS requirement under Nasdaq Listing Rule 5450(b)(2)(C).
These notices do not immediately delist the company; trading continues under the symbol "AFJK" pending compliance.
Outlook, Risks, and Management Commentary
Compliance Timeline: The company has a 180-day compliance period ending February 17, 2027, to regain compliance for both metrics. Compliance is achieved if the MVLS closes at or above $50 million and MVPHS at or above $15 million for 10 consecutive business days.
Management Strategy: Management intends to monitor metrics and consider available options to regain compliance. The company may apply to transfer to The Nasdaq Capital Market if it satisfies those requirements.
Risks: There is no assurance the company will successfully maintain its listing on the Nasdaq Global Market or successfully transfer to the Capital Market. Failure to comply by the deadline will result in delisting.
Investor Verification Checklist
- Verify the current market price and share count to calculate real-time MVLS and MVPHS.
- Monitor daily closing prices to track progress toward the 10-day compliance window.
- Review any subsequent filings for announcements regarding a potential transfer to the Nasdaq Capital Market.
- Check for any corporate actions (e.g., reverse stock splits) that might be proposed to address the market value deficiency.